3 European Projects Found
Searched on 125080 European Projects
FINISHED
Model-based preclinical development of anti-tuberculosis drug combinations (PREDICT-TB)
Start date: May 1, 2012, End date: Oct 30, 2017,
Drug development in TB requires new integrated methods to transition the novel combination regimens needed to shorten first-line therapy and combat multi-drug resistance. Although new agents are emerging, the path to registration of such regimens remains uncertain while capacity for pivotal trials is limited. Selection and optimization of drug combinations for development depends on preclinical sy ...
Read Project
23
Partners Participants
FINISHED
A stealth attack tool for preventing clinical drug resistance through a unique self-regenerating surface (BACATTACK)
Start date: Jan 1, 2012, End date: Dec 31, 2015,
Outbreaks of clinical infections affect many thousands of patients in Europe yearly. The present effective treatment for infections is large doses of systemically applied drugs. There is a high risk of recurring infections and biofilm formation for patients dependent on long term in-dwelling catheters and the extended dependency on antibiotics result in clinical drug resistance. We present a new t ...
Read Project
7
Partners Participants
FINISHED
The effects of antibiotic administration on the emergence and persistence of antibiotic-resistant bacteria in humans and on the composition of the indigenous microbiotas at various body sites (antiresdev)
Start date: Nov 1, 2009, End date: Apr 30, 2013,
The objective of the HEALTH-2009-2.3.1-2 call is to study the impact of different antibiotics on the prevalence of resistant bacteria in the human host. In ANTIRESDEV we will achieve this objective using the approaches suggested in the call as follows. We will use culture-based and culture-independent approaches to investigate the impact of four different types of antibiotics (with different modes ...
Read Project
